de Graaff B - Search Results

1

Healthcare costs attributable to diabetes in pregnancy: A cost of illness study in Tasmania, Australia.

Dinh TTN, de Graaff B, Campbell JA, Jose MD, Burgess J, Saunder T, Kitsos A, Palmer AJ. Dinh TTN, et al. Among authors: de graaff b. Diabet Med. 2024 Oct;41(10):e15417. doi: 10.1111/dme.15417. Epub 2024 Aug 2. Diabet Med. 2024. PMID: 39094024

2

Up, up and away: The growth of after-hours MBS claims.

de Graaff B, Nelson M, Neil A. de Graaff B, et al. Aust Fam Physician. 2017 Jun;46(6):407-411. Aust Fam Physician. 2017. PMID: 28609598 Free article.

3

A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions.

Si L, Winzenberg TM, de Graaff B, Palmer AJ. Si L, et al. Among authors: de graaff b. Osteoporos Int. 2014 Aug;25(8):1987-97. doi: 10.1007/s00198-014-2636-2. Epub 2014 Feb 22. Osteoporos Int. 2014. PMID: 24562840 Review.

4

A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis.

de Graaff B, Neil A, Sanderson K, Si L, Yee KC, Palmer AJ. de Graaff B, et al. Appl Health Econ Health Policy. 2015 Oct;13(5):469-83. doi: 10.1007/s40258-015-0189-y. Appl Health Econ Health Policy. 2015. PMID: 26255179 Review.

5

Quality of life utility values for hereditary haemochromatosis in Australia.

de Graaff B, Neil A, Sanderson K, Yee KC, Palmer AJ. de Graaff B, et al. Health Qual Life Outcomes. 2016 Feb 29;14:31. doi: 10.1186/s12955-016-0431-9. Health Qual Life Outcomes. 2016. PMID: 26922941 Free PMC article.

6

Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study.

de Graaff B, Neil A, Sanderson K, Yee KC, Palmer AJ. de Graaff B, et al. Aust Health Rev. 2017 Jul;41(3):254-267. doi: 10.1071/AH15188. Aust Health Rev. 2017. PMID: 27444148

7

Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia.

de Graaff B, Neil A, Si L, Yee KC, Sanderson K, Gurrin L, Palmer AJ. de Graaff B, et al. Appl Health Econ Health Policy. 2017 Aug;15(4):521-534. doi: 10.1007/s40258-016-0297-3. Appl Health Econ Health Policy. 2017. PMID: 28035629

8

Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model.

de Graaff B, Si L, Neil AL, Yee KC, Sanderson K, Gurrin LC, Palmer AJ. de Graaff B, et al. Pharmacoecon Open. 2017 Mar;1(1):37-51. doi: 10.1007/s41669-016-0005-0. Pharmacoecon Open. 2017. PMID: 29442300 Free PMC article.

9

Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia.

de Graaff B, Yee KC, Clarke P, Palmer A. de Graaff B, et al. Appl Health Econ Health Policy. 2018 Aug;16(4):495-502. doi: 10.1007/s40258-018-0392-8. Appl Health Econ Health Policy. 2018. PMID: 29675692

10

The role of intergenerational educational mobility and household wealth in adult obesity: Evidence from Wave 2 of the World Health Organization's Study on global AGEing and adult health.

Lartey ST, Magnussen CG, Si L, de Graaff B, Biritwum RB, Mensah G, Yawson A, Minicuci N, Kowal P, Boateng GO, Palmer AJ. Lartey ST, et al. Among authors: de graaff b. PLoS One. 2019 Jan 9;14(1):e0208491. doi: 10.1371/journal.pone.0208491. eCollection 2019. PLoS One. 2019. PMID: 30625141 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters